Publications by authors named "Fredrik Albach"

Claim this Profile
T
Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome.
Elpida Phithak, Fredrik N Albach, Ioanna Minopoulou, Robert Biesen, Arnd Kleyer

Ann Rheum Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease.
Thorben Witte, Ioanna Minopoulou, Norman Michael Drzeniek, Murat Torgutalp, Robert Sabat, Fredrik Albach

Autoimmun Rev· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting autoimmunity with CD19-CAR T-cell therapy: efficacy and seroconversion in diffuse systemic sclerosis and rheumatoid arthritis.
Fredrik N Albach, Ioanna Minopoulou, Artur Wilhelm, Robert Biesen, Arnd Kleyer

Rheumatology (Oxford)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitis.
Ioanna Minopoulou, Artur Wilhelm, Fredrik Albach, Arnd Kleyer, Edgar Wiebe

Ann Rheum Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unconventional Imaging Methods in Psoriatic Arthritis.
Ioanna Minopoulou, Filippo Fagni, Armin Atzinger, Fredrik Albach, Georg Schett

Curr Rheumatol Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple Sclerosis.
Fredrik N Albach, Christian Geier, Christian Keicher, Maximilian G Posch, Stephan J Schreiber

Neurol Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Head-to-head studies on psoriasis and psoriatic arthritis].
Fredrik N Albach, Michaela Köhm, David Simon

Z Rheumatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic antibodies inhibit spike-specific T and B cell responses after COVID-19 vaccination.
Henrik E Mei, Axel Ronald Schulz, Heike Hirseland, Lisa-Marie Diekmann, Elisa Habermann, Fredrik Albach

J Med Virol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Therapeutic antibodies in rheumatology].
Fredrik N Albach, Gerd-Rüdiger Burmester, Johanna Mucke

Z Rheumatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recovery of hearing loss, depression and erosive polyarthritis after diagnosis of Whipple's disease.
Robert Biesen, Tobias Alexander, Gerd-Rüdiger Burmester, Fredrik N Albach

Rheumatol Adv Pract· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of humoral immunity by repeated dose-intensified COVID-19 vaccinations in primary non- to low-responders and B cell deficient rheumatic disease patients.
Alexander Ten Hagen, Sandra Hermann, Elisa Habermann, Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Fredrik N Albach

J Autoimmun· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series.
Alexander Ten Hagen, Elisa Habermann, Sandra Hermann, Gerd R Burmester, Robert Biesen, Fredrik N Albach

RMD Open· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease.
Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, Veronika Scholz, Tanja Braun, Fredrik N Albach

RMD Open· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination.
Elisa Habermann, Lutz Gieselmann, Pinkus Tober-Lau, Jens Klotsche, Fredrik Nils Albach

RMD Open· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases.
Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Fredrik N Albach, Jens Klotsche, Veronika Scholz

Ann Rheum Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response.
Fredrik N Albach, Gerd R Burmester, Robert Biesen

Ann Rheum Dis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics and pharmacodynamics of single rising doses of BI 655064, an antagonistic anti-CD40 antibody in healthy subjects: a potential novel treatment for autoimmune diseases.
Fredrik N Albach, Frank Wagner, Andreas Hüser, Julia Igel, David Joseph

Eur J Clin Pharmacol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early new diffusion-weighted imaging lesions appear more often in stroke patients with a multiple territory lesion pattern.
Tim Bastian Braemswig, Tatiana Usnich, Fredrik N Albach, Peter Brunecker, Ulrike Grittner

Stroke· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete early reversal of diffusion-weighted imaging hyperintensities after ischemic stroke is mainly limited to small embolic lesions.
Fredrik N Albach, Peter Brunecker, Tatiana Usnich, Kersten Villringer, Martin Ebinger

Stroke· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of new diffusion-weighted imaging lesions outside the area of initial hypoperfusion within 1 week after acute ischemic stroke.
Tatiana Usnich, Fredrik N Albach, Peter Brunecker, Jochen B Fiebach, Christian H Nolte

Stroke· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silent new DWI lesions within the first week after stroke.
Christian H Nolte, Fredrik N Albach, Peter U Heuschmann, Peter Brunecker, Kersten Villringer

Cerebrovasc Dis· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis